Crispr Therapeutics shares owned by Ikarian Capital
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Ikarian Capital
from 13F filings
Historical chart of Ikarian Capital investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Ikarian Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $45M | 724k | 62.60 |
| 2023-09-30 | $1.5M | 33k | 45.39 |
| 2023-06-30 | $23M | 400k | 56.14 |
| 2021-09-30 | $25M | 225k | 111.93 |
| 2021-06-30 | $52M | 320k | 161.89 |
| 2021-03-31 | $6.9M | 57k | 121.84 |
| 2020-12-31 | $18M | 115k | 153.11 |
| 2020-09-30 | $9.6M | 115k | 83.64 |
| 2020-06-30 | $13M | 179k | 73.49 |
| 2020-03-31 | $7.6M | 179k | 42.41 |
| 2019-12-31 | $7.5M | 124k | 60.91 |